Career Development Awards in Global Health
Career development awards provide funding to support a postdoctoral or early career researcher committed to global research, who needs both advanced research training and additional experience.
CGH supports two types of awards: The Emerging Global Leader award for LMIC scientists and the International Research Scientist Development Award for U.S. postdoctoral scientists interested in global cancer research. Both programs are led by NIH’s Fogarty International Center. NCI supports applicants who score well in peer review, depending on the availability of funds.
Emerging Global Leader Award
The Emerging Global Leader Award is only for LMIC scientists.
How to Apply
Find current announcements—along with detailed award descriptions, application deadlines, and application instructions—on Fogarty International Center's Emerging Global Leader Award page. We recommend that applicants also contact the scientific contact for NCI whose details are listed at the end of the notices.
Past-Funded Awards
The table below is a list of all funded cancer projects under NIH’s Emerging Global Leader Award.
* Denotes grants co-funded by NCI
| Grant No. | Title | PI | Institution | Country | Dates |
|---|---|---|---|---|---|
| K43TW011387* | Novel Prostate Cancer Cell Lines to Address Prostate Cancer Disparity in Black Men | Simone Annmarie Badal | Univ. of West Indies | Jamaica | 2020-2025 |
| K43CA268978* | A Clinical Prediction Rule For Identifying South African Colorectal Cancer Patients Who Will Fail To Engage In Oncology Care | Yoshan Moodley | Univ. of Kwazulu Natal | South Africa | 2021-2026 |
| K43TW011095* | Biomarkers of Kaposi Sarcoma Recrudescence in Zambia | Owen Ngalamika | Univ. of Zambia | Zambia | 2018-2023 |
| K43TW010721* | Treatment response and microrna profiles in triple negative breast cancer patients receiving standard chemotherapy (TARMAC) | Atara Isaiah Ntekim | Univ. of Ibadan | Nigeria | 2018-2023 |
| K43TW011418* | Plasma and cellular immune biomarkers of Kaposis sarcoma in HIV-1 suppressed patients | Salum Juma Lidenge | Ocean Road Cancer Inst. | Tanzania | 2019-2024 |
| K43TW011942* | Early life aflatoxin B1 exposure and epigenetic programming in Nigerian Newborns | Oluwakemi Anuoluwapo Rotimi | Covenant University | Nigeria | 2022-2027 |
| K43TW011987* | Quantifying, Explaining and Predicting Survival After Diagnosis of HIV-related Kaposi Sarcoma in East Africa | Helen Byakwaga | Makerere University | Uganda | 2021-2026 |
| K43TW011986* | Defining the biology of HIV-associated aggressive B-cell lymphoma in Southern Africa | Katherine Antel | Univ. of Capetown | South Africa | 2021-2026 |
| K43TW011930* | Comparative assessment of p16/Ki-67 dual Staining Technology in women living with HIV | Kehinde Sharafadeen Okunade | Univ. of Lagos | Nigeria | 2022-2027 |
| K43TW011416 | Vaginal Microbiome in Cervical Intraepithelial Neoplasia and Cancer | Jonah Musa | University of Jos | Nigeria | 2019-2024 |
| K43TW010715 | Polycyclic aromatic hydrocarbons exposure and dietary risk of Esophageal squamous cell carcinoma in Uganda | Samson Okello | Mbarara Univ. of Science and Technology | Uganda | 2017-2022 |
| K43TW011926 | Prevalence and temporal dynamics of clonal mutations associated with the risk of hematological cancer in a cohort of clinically healthy Nigerians | Kolapo Oyebola | Univ. of Lagos | Nigeria | 2021-2026 |
International Research Scientist Development Award (IRSDA)
The Emerging Global Leader Award is for U.S. postdoctoral scientists interested in global cancer research.
How to Apply
Find current announcements—along with detailed award descriptions, application deadlines, and application instructions—on Fogarty International Center's International Research Scientist Development Award (IRSDA) page. We recommend that applicants also contact the scientific contact for NCI whose details are listed at the end of the notices.
Past-Funded Awards
The table below is a list of all funded cancer projects under NIH’s International Research Scientist Development Award (IRDSA).
| Grant No. | Title | PI | Institution | Country | Dates |
|---|---|---|---|---|---|
| K01TW010271 | Metabolic Syndrome and Epigenetic Markers of Breast Cancer in Nigerian Women | Tomi F. Akinyemiju | Duke Univ., Durhem | Nigeria | 2016-2021 |
| K01TW011191 | Understanding Methotrexate Dosing, Pharmacokinetics, and Toxicities for Burkitt Lymphoma in Maiawi | Katherine Westmoreland | Univ. of North Carolina, Chapel Hill | Malawi | 2019-2024 |
| K01TW011481 | Fidelity and Adaptation of Breast Cancer Resource-stratified Treatment Guidelines in Botswana | Yehoda Marteki Martei | Univ. of Pennsylvania | Botswana | 2020-2024 |
| K01TW012174 | Adaptation and Pilot of a Peer-Facilitated Self-Help Plus Stress Management Intervention for Breast Cancer Patients in Vietnam | Phuongthao Dinh Le | Boston Univ. | Vietnam | 2021-2026 |
| K01TW012181 | Improving Access to Cancer Care for Children in Tanzania: Designing a Health-systems Intervention | Emily Smith | Duke Univ. | Tanzania | 2022-2027 |
| K01TW011470 | Safety, Efficacy, and Cost-effectiveness of Rituximab for Multicentric Castleman Disease in Malawi | Matthew Scott Painschab | Univ. of North Carolina, Chapel Hill | Malawi | 2019-2024 |
| K01TW010494 | Reducing Barriers and Sustaining Utilization of a Cervical Cancer Screening Program in Rural Senegal | Jon Andrew Dykens | Univ. of Illinois, Chicago | Senegal | 2016-2022 |
| K01TW009488 | Developing a Clinical Cohort of Histo-pathologically Characterized Lymphoma | Satish Gopal | Univ. of North Carolina, Chapel Hill | Malawi | 2012-2017 |
| K01TW008409 | Radiotherapy Outcomes for Children in Developing Versus Developed Countries | Phillip J. Taddei | Univ. of Texas, MD Anderson Cancer Center | Lebanon | 2010-2015 |
| K01TW008414 | Examining Human Behavior in Dengue Prevention Efforts in Iquitos, Peru | Valerie Andrea Paz-Soldan | Tulane Univ. Of Louisiana | Peru | 2010-2015 |